David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Liberty Global Class C
LBTYK
|
+$404M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$361M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$327M |
| 4 |
Procter & Gamble
PG
|
+$313M |
| 5 |
Netflix
NFLX
|
+$286M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
Bank of America
BAC
|
+$405M |
| 3 |
LIFE
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
|
+$236M |
| 4 |
Citigroup
C
|
+$219M |
| 5 |
SLB Ltd
SLB
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 9.3% |
| 2 | Healthcare | 8.21% |
| 3 | Consumer Discretionary | 8.05% |
| 4 | Energy | 7.7% |
| 5 | Technology | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Procter & Gamble
PG
$336B
| $356M | 0.51% |
4,411,287
+3,972,423
| +905% | +$313M |
|
27
Microsoft
MSFT
$3.59T
| $337M | 0.48% |
8,232,155
+940,369
| +13% | +$35.3M |
|
28
DaVita
DVA
$11.1B
| $329M | 0.47% |
4,774,324
+269,691
| +6% | +$17.9M |
|
29
Merck
MRK
$376B
| $319M | 0.46% |
5,891,033
-1,460,091
| -20% | -$75.6M |
|
30
AbbVie
ABBV
$468B
| $301M | 0.43% |
5,859,863
+2,262,977
| +63% | +$114M |
|
31
Occidental Petroleum
OXY
$61.3B
| $294M | 0.42% |
3,223,411
+485,137
| +18% | +$43.3M |
|
32
Visa
V
$693B
| $293M | 0.42% |
5,428,744
+3,174,644
| +141% | +$176M |
|
|
DTV
33
DELISTED
DIRECTV COM STK (DE)
DTV
| $291M | 0.42% |
3,811,796
+1,473,943
| +63% | +$108M |
|
34
Constellation Brands
STZ
$23.2B
| $290M | 0.41% |
3,414,725
+649,633
| +23% | +$51.7M |
|
35
Bausch Health
BHC
$2.41B
| $289M | 0.41% |
2,191,015
+609,949
| +39% | +$83.4M |
|
|
APC
36
DELISTED
Anadarko Petroleum
APC
| $278M | 0.4% |
3,278,846
+1,031,014
| +46% | +$84.5M |
|
|
FRX
37
DELISTED
FOREST LABORATORIES INC
FRX
| $268M | 0.38% |
2,904,978
+2,011,620
| +225% | +$162M |
|
38
Johnson & Johnson
JNJ
$651B
| $268M | 0.38% |
2,728,041
-1,932,802
| -41% | -$179M |
|
39
PUT
Mastercard
MA
$509B
| $267M | 0.38% |
3,578,700
-1,315,300
| -27% | -$103M |
|
40
Wells Fargo
WFC
$254B
| $263M | 0.37% |
5,283,923
-659,632
| -11% | -$30.7M |
|
|
YHOO
41
PUT
DELISTED
Yahoo Inc
YHOO
| $261M | 0.37% |
7,277,000
-1,403,900
| -16% | -$53.6M |
|
42
Verizon
VZ
$205B
| $257M | 0.37% |
5,406,637
+5,222,151
| +2,831% | +$247M |
|
|
43
PUT
Johnson & Johnson
JNJ
$651B
| $255M | 0.36% |
2,599,200
-477,500
| -16% | -$44.3M |
|
44
Thermo Fisher Scientific
TMO
$233B
| $254M | 0.36% |
2,109,938
+553,879
| +36% | +$65.9M |
|
45
CALL
Booking.com
BKNG
$158B
| $251M | 0.36% |
5,270,000
+1,047,500
| +25% | +$51.7M |
|
46
Pfizer
PFE
$160B
| $251M | 0.36% |
8,223,341
+5,084,512
| +162% | +$152M |
|
47
CF Industries
CF
$19.6B
| $244M | 0.35% |
4,676,455
-79,505
| -2% | -$3.87M |
|
48
PUT
Micron Technology
MU
$1.09T
| $243M | 0.35% |
10,279,400
+2,151,000
| +26% | +$51.1M |
|
|
MHFI
49
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $242M | 0.35% |
3,175,564
+1,634,279
| +106% | +$128M |
|
|
EMC
50
DELISTED
EMC CORPORATION
EMC
| $240M | 0.34% |
8,748,477
+6,842,084
| +359% | +$178M |
|
Similar funds
David Shaw's Q1 2014 Portfolio in Review
As of Q1 2014, David Shaw held 5,020 positions worth $70.1B, down 4.4% from $73.3B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw withdrew a net $4.59B in Q1 2014, closing 795 positions and reducing 1,925 holdings. Its most notable exit was LIFE TECHNOLOGIES CORP COM STK (DE), an estimated $236M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 9.3% of assets, up from 6.6% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Veren worth $53.3M.
- David Shaw's largest Q1 2014 buy was Veren: 1,596,878 shares worth $53.3M.
- David Shaw added most to Liberty Global Class C in Q1 2014, an estimated $404M increase.
- David Shaw's biggest Q1 2014 reduction was Apple, cutting an estimated $453M.
- David Shaw fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $236M.
- David Shaw's ten largest holdings make up 10% of its $70.1B portfolio in Q1 2014.
- David Shaw opened 596 new positions and closed 795 in Q1 2014.
- David Shaw's portfolio value fell 4.4% quarter-over-quarter to $70.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2014, filed 15 May 2014.